Knowledge Center

Ultragenyx Reports Positive Initial Data on DTX401 Clinical Trial

On May 15, Ultragenyx Pharmaceutical Inc. (RARE) presented positive initial data from all three cohorts in its DTX401 clinical trial. DTX401 is an adeno-associated virus-based gene therapy. It is undergoing clinical trials for the treatment of glycogen storage disease type 1a (GSD1a). All patients demonstrated significant cornstarch reductions over time and increases in time to […]

Read more...

Kratos Awarded Sole-Source Contract from U.S. Space Force

On May 4, Kratos Defense & Security Solutions, Inc. (KTOS) announced that it was awarded a sole-source contract with the U.S. Space Force. Under the terms of the contract, Kratos will provide satellite bandwidth utilization services and continuous monitoring of commercial satellites leased by the U.S. Space Force. The contract is valued at just over […]

Read more...

April 2020 Scorecard

The April 2020 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide

Read more...

Akebia Announces Positive Phase 3 Clinical Trial Results

Akebia Therapeutics, Inc. (AKBA) announced positive top-line results on May 5 for the first of its two Phase 3 cardiovascular outcomes programs. The two INNO2VATE studies evaluated the efficacy and safety of Akebia’s drug vadadustat. The drug treats anemia due to chronic kidney disease in adult patients on kidney dialysis. The studies indicate that the treatment […]

Read more...

FDA Grants Accelerated Approval to Immunomedics for Trodelvy in Breast Cancer Patients

On April 22, Immunomedics, Inc. (IMMU) announced that they received accelerated FDA approval of Trodelvy™ (sacituzumab govitecan-hziy) for the treatment of adult patients with metastatic triple-negative breast cancer (TNBC). The treatment is specifically for patents who have received at least two prior therapies for metastatic disease. This is a particularly aggressive form of cancer for […]

Read more...

GenMark Diagnostics Provides Preliminary Financials for First Quarter and Increases Guidance for 2020

On April 7, GenMark Diagnostics, Inc. (GNMK) provided preliminary financial results for the quarter ending March 31, 2020. During the first quarter, GenMark received FDA emergency use authorization for its ePlex SARS-CoV-2 Test. Total revenue estimates for the first quarter are $38.7 million, which is an 80% increase over the first quarter of 2019. GenMark […]

Read more...

Scientific Games Wins 10-year Iowa Lottery Contract

Scientific Games Corporation (SGMS) announced on April 7 that the company won a new 10-year contract with the Iowa Lottery. Scientific Games will provide a new statewide gaming system for the 2,400 retail locations where Iowa Lottery games are sold. Over the last eight years, Scientific Games has helped the Iowa Lottery to increase sales […]

Read more...

March 2020 Scorecard

The March 2020 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide

Read more...

New York State Department of Financial Services Reapproves China Oceanwide’s Acquisition of Genworth Life Insurance

New York State Department of Financial Services reapproved a previous proposal for China Oceanwide Holdings Group Co. Ltd. (Oceanwide)’s acquisition of Genworth Life Insurance Company of New York (GLICNY). Genworth Financial, the parent company of Genworth Life Insurance, reported the news with Oceanwide on March 24. The New York State Department of Financial Services had […]

Read more...